Global and Japan Vaccines For Children (VFC) Market Insights, Forecast to 2027
SKU ID : QYR-19222348 | Publishing Date : 24-Sep-2021 | No. of pages : 149
Detailed TOC of Global and Japan Vaccines For Children (VFC) Market Insights, Forecast to 2027
1 Study Coverage1.1 Vaccines For Children (VFC) Product Introduction
1.2 Market by Type
1.2.1 Global Vaccines For Children (VFC) Market Size Growth Rate by Type
1.2.2 Recombinant Vaccines
1.2.3 Viral Vaccines
1.2.4 Polysaccharide Vaccines
1.2.5 Others
1.3 Market by Application
1.3.1 Global Vaccines For Children (VFC) Market Size Growth Rate by Application
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Vaccines For Children (VFC) Market Size, Estimates and Forecasts
2.1.1 Global Vaccines For Children (VFC) Revenue 2016-2027
2.1.2 Global Vaccines For Children (VFC) Sales 2016-2027
2.2 Global Vaccines For Children (VFC), Market Size by Region: 2016 VS 2021 VS 2027
2.3 Vaccines For Children (VFC) Historical Market Size by Region (2016-2021)
2.3.1 Global Vaccines For Children (VFC) Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Vaccines For Children (VFC) Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Vaccines For Children (VFC) Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Vaccines For Children (VFC) Sales Forecast by Region (2022-2027)
2.4.2 Global Vaccines For Children (VFC) Revenue Forecast by Region (2022-2027)
3 Global Vaccines For Children (VFC) Competitor Landscape by Players
3.1 Global Top Vaccines For Children (VFC) Manufacturers by Sales
3.1.1 Global Vaccines For Children (VFC) Sales by Manufacturer (2016-2021)
3.1.2 Global Vaccines For Children (VFC) Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Vaccines For Children (VFC) Manufacturers by Revenue
3.2.1 Key Vaccines For Children (VFC) Manufacturers Covered: Ranking by Revenue
3.2.2 Global Vaccines For Children (VFC) Revenue by Manufacturers (2016-2021)
3.2.3 Global Vaccines For Children (VFC) Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Vaccines For Children (VFC) Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Vaccines For Children (VFC) Revenue in 2020
3.2.6 Global Vaccines For Children (VFC) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Vaccines For Children (VFC) Price by Manufacturers
3.4 Global Vaccines For Children (VFC) Manufacturing Base Distribution, Product Types
3.4.1 Vaccines For Children (VFC) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Vaccines For Children (VFC) Product Type
3.4.3 Date of International Manufacturers Enter into Vaccines For Children (VFC) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Vaccines For Children (VFC) Market Size by Type (2016-2021)
4.1.1 Global Vaccines For Children (VFC) Sales by Type (2016-2021)
4.1.2 Global Vaccines For Children (VFC) Revenue by Type (2016-2021)
4.1.3 Vaccines For Children (VFC) Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Vaccines For Children (VFC) Market Size Forecast by Type (2022-2027)
4.2.1 Global Vaccines For Children (VFC) Sales Forecast by Type (2022-2027)
4.2.2 Global Vaccines For Children (VFC) Revenue Forecast by Type (2022-2027)
4.2.3 Vaccines For Children (VFC) Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Vaccines For Children (VFC) Market Size by Application (2016-2021)
5.1.1 Global Vaccines For Children (VFC) Sales by Application (2016-2021)
5.1.2 Global Vaccines For Children (VFC) Revenue by Application (2016-2021)
5.1.3 Vaccines For Children (VFC) Price by Application (2016-2021)
5.2 Vaccines For Children (VFC) Market Size Forecast by Application (2022-2027)
5.2.1 Global Vaccines For Children (VFC) Sales Forecast by Application (2022-2027)
5.2.2 Global Vaccines For Children (VFC) Revenue Forecast by Application (2022-2027)
5.2.3 Global Vaccines For Children (VFC) Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Vaccines For Children (VFC) Market Size YoY Growth 2016-2027
6.1.1 Japan Vaccines For Children (VFC) Sales YoY Growth 2016-2027
6.1.2 Japan Vaccines For Children (VFC) Revenue YoY Growth 2016-2027
6.1.3 Japan Vaccines For Children (VFC) Market Share in Global Market 2016-2027
6.2 Japan Vaccines For Children (VFC) Market Size by Players (International and Local Players)
6.2.1 Japan Top Vaccines For Children (VFC) Players by Sales (2016-2021)
6.2.2 Japan Top Vaccines For Children (VFC) Players by Revenue (2016-2021)
6.3 Japan Vaccines For Children (VFC) Historic Market Review by Type (2016-2021)
6.3.1 Japan Vaccines For Children (VFC) Sales Market Share by Type (2016-2021)
6.3.2 Japan Vaccines For Children (VFC) Revenue Market Share by Type (2016-2021)
6.3.3 Japan Vaccines For Children (VFC) Price by Type (2016-2021)
6.4 Japan Vaccines For Children (VFC) Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Vaccines For Children (VFC) Sales Forecast by Type (2022-2027)
6.4.2 Japan Vaccines For Children (VFC) Revenue Forecast by Type (2022-2027)
6.4.3 Japan Vaccines For Children (VFC) Price Forecast by Type (2022-2027)
6.5 Japan Vaccines For Children (VFC) Historic Market Review by Application (2016-2021)
6.5.1 Japan Vaccines For Children (VFC) Sales Market Share by Application (2016-2021)
6.5.2 Japan Vaccines For Children (VFC) Revenue Market Share by Application (2016-2021)
6.5.3 Japan Vaccines For Children (VFC) Price by Application (2016-2021)
6.6 Japan Vaccines For Children (VFC) Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Vaccines For Children (VFC) Sales Forecast by Application (2022-2027)
6.6.2 Japan Vaccines For Children (VFC) Revenue Forecast by Application (2022-2027)
6.6.3 Japan Vaccines For Children (VFC) Price Forecast by Application (2022-2027)
7 North America
7.1 North America Vaccines For Children (VFC) Market Size YoY Growth 2016-2027
7.2 North America Vaccines For Children (VFC) Market Facts & Figures by Country
7.2.1 North America Vaccines For Children (VFC) Sales by Country (2016-2021)
7.2.2 North America Vaccines For Children (VFC) Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Vaccines For Children (VFC) Market Size YoY Growth 2016-2027
8.2 Asia Pacific Vaccines For Children (VFC) Market Facts & Figures by Region
8.2.1 Asia Pacific Vaccines For Children (VFC) Sales by Region (2016-2021)
8.2.2 Asia Pacific Vaccines For Children (VFC) Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Vaccines For Children (VFC) Market Size YoY Growth 2016-2027
9.2 Europe Vaccines For Children (VFC) Market Facts & Figures by Country
9.2.1 Europe Vaccines For Children (VFC) Sales by Country (2016-2021)
9.2.2 Europe Vaccines For Children (VFC) Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Vaccines For Children (VFC) Market Size YoY Growth 2016-2027
10.2 Latin America Vaccines For Children (VFC) Market Facts & Figures by Country
10.2.1 Latin America Vaccines For Children (VFC) Sales by Country (2016-2021)
10.2.2 Latin America Vaccines For Children (VFC) Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Vaccines For Children (VFC) Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Vaccines For Children (VFC) Market Facts & Figures by Country
11.2.1 Middle East and Africa Vaccines For Children (VFC) Sales by Country (2016-2021)
11.2.2 Middle East and Africa Vaccines For Children (VFC) Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Description and Business Overview
12.1.3 GSK Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GSK Vaccines For Children (VFC) Products Offered
12.1.5 GSK Recent Development
12.2 Sanofi
12.2.1 Sanofi Corporation Information
12.2.2 Sanofi Description and Business Overview
12.2.3 Sanofi Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sanofi Vaccines For Children (VFC) Products Offered
12.2.5 Sanofi Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Description and Business Overview
12.3.3 Merck Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck Vaccines For Children (VFC) Products Offered
12.3.5 Merck Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Description and Business Overview
12.4.3 Pfizer Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Pfizer Vaccines For Children (VFC) Products Offered
12.4.5 Pfizer Recent Development
12.5 Jintan
12.5.1 Jintan Corporation Information
12.5.2 Jintan Description and Business Overview
12.5.3 Jintan Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Jintan Vaccines For Children (VFC) Products Offered
12.5.5 Jintan Recent Development
12.6 CSL
12.6.1 CSL Corporation Information
12.6.2 CSL Description and Business Overview
12.6.3 CSL Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 CSL Vaccines For Children (VFC) Products Offered
12.6.5 CSL Recent Development
12.7 MedImmune LLC
12.7.1 MedImmune LLC Corporation Information
12.7.2 MedImmune LLC Description and Business Overview
12.7.3 MedImmune LLC Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 MedImmune LLC Vaccines For Children (VFC) Products Offered
12.7.5 MedImmune LLC Recent Development
12.8 J&J(Crucell)
12.8.1 J&J(Crucell) Corporation Information
12.8.2 J&J(Crucell) Description and Business Overview
12.8.3 J&J(Crucell) Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 J&J(Crucell) Vaccines For Children (VFC) Products Offered
12.8.5 J&J(Crucell) Recent Development
12.9 China National Biotec
12.9.1 China National Biotec Corporation Information
12.9.2 China National Biotec Description and Business Overview
12.9.3 China National Biotec Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 China National Biotec Vaccines For Children (VFC) Products Offered
12.9.5 China National Biotec Recent Development
12.10 Tiantan
12.10.1 Tiantan Corporation Information
12.10.2 Tiantan Description and Business Overview
12.10.3 Tiantan Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Tiantan Vaccines For Children (VFC) Products Offered
12.10.5 Tiantan Recent Development
12.11 GSK
12.11.1 GSK Corporation Information
12.11.2 GSK Description and Business Overview
12.11.3 GSK Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 GSK Vaccines For Children (VFC) Products Offered
12.11.5 GSK Recent Development
12.12 Kangtai
12.12.1 Kangtai Corporation Information
12.12.2 Kangtai Description and Business Overview
12.12.3 Kangtai Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Kangtai Products Offered
12.12.5 Kangtai Recent Development
12.13 Hissen
12.13.1 Hissen Corporation Information
12.13.2 Hissen Description and Business Overview
12.13.3 Hissen Vaccines For Children (VFC) Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Hissen Products Offered
12.13.5 Hissen Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Vaccines For Children (VFC) Industry Trends
13.2 Vaccines For Children (VFC) Market Drivers
13.3 Vaccines For Children (VFC) Market Challenges
13.4 Vaccines For Children (VFC) Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Vaccines For Children (VFC) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global and Japan Vaccines For Children (VFC) Market Insights, Forecast to 2027
List of TablesTable 1. Global Vaccines For Children (VFC) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Recombinant Vaccines
Table 3. Major Manufacturers of Viral Vaccines
Table 4. Major Manufacturers of Polysaccharide Vaccines
Table 5. Major Manufacturers of Others
Table 6. Global Vaccines For Children (VFC) Market Size Growth Rate by Application (2021-2027) & (K Doses)
Table 7. Global Vaccines For Children (VFC) Market Size by Region (K Doses) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Vaccines For Children (VFC) Sales by Regions (2016-2021) & (K Doses)
Table 9. Global Vaccines For Children (VFC) Sales Market Share by Regions (2016-2021)
Table 10. Global Vaccines For Children (VFC) Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Vaccines For Children (VFC) Sales Forecast by Region (2022-2027) & (K Doses)
Table 12. Global Vaccines For Children (VFC) Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Vaccines For Children (VFC) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Vaccines For Children (VFC) Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Vaccines For Children (VFC) Sales by Manufacturers (2016-2021) (K Doses)
Table 16. Global Vaccines For Children (VFC) Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Vaccines For Children (VFC) Manufacturers by Revenue (US$ Million) in 2020
Table 18. Vaccines For Children (VFC) Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Vaccines For Children (VFC) Revenue Share by Manufacturers (2016-2021)
Table 20. Global Vaccines For Children (VFC) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Vaccines For Children (VFC) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccines For Children (VFC) as of 2020)
Table 22. Key Manufacturers Vaccines For Children (VFC) Price (2016-2021) (US$/Dose)
Table 23. Vaccines For Children (VFC) Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Vaccines For Children (VFC) Product Type
Table 25. Date of International Manufacturers Enter into Vaccines For Children (VFC) Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Vaccines For Children (VFC) Sales by Type (2016-2021) (K Doses)
Table 28. Global Vaccines For Children (VFC) Sales Share by Type (2016-2021)
Table 29. Global Vaccines For Children (VFC) Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Vaccines For Children (VFC) Revenue Share by Type (2016-2021)
Table 31. Vaccines For Children (VFC) Average Selling Price (ASP) by Type (2016-2021) & (US$/Dose)
Table 32. Global Vaccines For Children (VFC) Sales Forecast by Type (2022-2027) & (K Doses)
Table 33. Global Vaccines For Children (VFC) Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Vaccines For Children (VFC) Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Vaccines For Children (VFC) Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Vaccines For Children (VFC) Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Dose)
Table 37. Global Vaccines For Children (VFC) Sales by Application (2016-2021) (K Doses)
Table 38. Global Vaccines For Children (VFC) Sales Share by Application (2016-2021)
Table 39. Global Vaccines For Children (VFC) Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Vaccines For Children (VFC) Revenue Share by Application (2016-2021)
Table 41. Vaccines For Children (VFC) Average Selling Price (ASP) by Application (2016-2021) & (US$/Dose)
Table 42. Global Vaccines For Children (VFC) Sales Forecast by Application (2022-2027) & (K Doses)
Table 43. Global Vaccines For Children (VFC) Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Vaccines For Children (VFC) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Vaccines For Children (VFC) Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Vaccines For Children (VFC) Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Dose)
Table 47. Japan Vaccines For Children (VFC) Sales (K Doses) of Key Companies (2016-2021)
Table 48. Japan Vaccines For Children (VFC) Sales Share by Company (2016-2021)
Table 49. Japan Vaccines For Children (VFC) Revenue (US$ Million) by Company (2016-2021)
Table 50. Japan Vaccines For Children (VFC) Revenue Share by Company (2016-2021)
Table 51. Japan Vaccines For Children (VFC) Sales (K Doses) by Type (2016-2021)
Table 52. Japan Vaccines For Children (VFC) Sales Share by Type (2016-2021)
Table 53. Japan Vaccines For Children (VFC) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. Japan Vaccines For Children (VFC) Price (US$/Dose) by Type (2016-2021)
Table 55. Japan Vaccines For Children (VFC) Sales (K Doses) by Type (2022-2027)
Table 56. Japan Vaccines For Children (VFC) Sales Share by Type (2022-2027)
Table 57. Japan Vaccines For Children (VFC) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. Japan Vaccines For Children (VFC) Revenue Share by Type (2022-2027)
Table 59. Japan Vaccines For Children (VFC) Price (US$/Dose) by Type (2022-2027)
Table 60. Japan Vaccines For Children (VFC) Sales (K Doses) by Application (2016-2021)
Table 61. Japan Vaccines For Children (VFC) Sales Share by Application (2016-2021)
Table 62. Japan Vaccines For Children (VFC) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. Japan Vaccines For Children (VFC) Price (US$/Dose) by Application (2016-2021)
Table 64. Japan Vaccines For Children (VFC) Sales (K Doses) by Application (2022-2027)
Table 65. Japan Vaccines For Children (VFC) Sales Share by Application (2022-2027)
Table 66. Japan Vaccines For Children (VFC) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. Japan Vaccines For Children (VFC) Revenue Share by Application (2022-2027)
Table 68. Japan Vaccines For Children (VFC) Price (US$/Dose) by Application (2022-2027)
Table 69. North America Vaccines For Children (VFC) Sales by Country (2016-2021) & (K Doses)
Table 70. North America Vaccines For Children (VFC) Sales Market Share by Country (2016-2021)
Table 71. North America Vaccines For Children (VFC) Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Vaccines For Children (VFC) Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Vaccines For Children (VFC) Sales by Region (2016-2021) & (K Doses)
Table 74. Asia Pacific Vaccines For Children (VFC) Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Vaccines For Children (VFC) Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Vaccines For Children (VFC) Revenue Market Share by Region (2016-2021)
Table 77. Europe Vaccines For Children (VFC) Sales by Country (2016-2021) & (K Doses)
Table 78. Europe Vaccines For Children (VFC) Sales Market Share by Country (2016-2021)
Table 79. Europe Vaccines For Children (VFC) Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Vaccines For Children (VFC) Revenue Market Share by Country (2016-2021)
Table 81. Latin America Vaccines For Children (VFC) Sales by Country (2016-2021) & (K Doses)
Table 82. Latin America Vaccines For Children (VFC) Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Vaccines For Children (VFC) Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Vaccines For Children (VFC) Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Vaccines For Children (VFC) Sales by Country (2016-2021) & (K Doses)
Table 86. Middle East and Africa Vaccines For Children (VFC) Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Vaccines For Children (VFC) Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Vaccines For Children (VFC) Revenue Market Share by Country (2016-2021)
Table 89. GSK Corporation Information
Table 90. GSK Description and Business Overview
Table 91. GSK Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 92. GSK Vaccines For Children (VFC) Product
Table 93. GSK Recent Development
Table 94. Sanofi Corporation Information
Table 95. Sanofi Description and Business Overview
Table 96. Sanofi Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 97. Sanofi Product
Table 98. Sanofi Recent Development
Table 99. Merck Corporation Information
Table 100. Merck Description and Business Overview
Table 101. Merck Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 102. Merck Product
Table 103. Merck Recent Development
Table 104. Pfizer Corporation Information
Table 105. Pfizer Description and Business Overview
Table 106. Pfizer Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 107. Pfizer Product
Table 108. Pfizer Recent Development
Table 109. Jintan Corporation Information
Table 110. Jintan Description and Business Overview
Table 111. Jintan Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 112. Jintan Product
Table 113. Jintan Recent Development
Table 114. CSL Corporation Information
Table 115. CSL Description and Business Overview
Table 116. CSL Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 117. CSL Product
Table 118. CSL Recent Development
Table 119. MedImmune LLC Corporation Information
Table 120. MedImmune LLC Description and Business Overview
Table 121. MedImmune LLC Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 122. MedImmune LLC Product
Table 123. MedImmune LLC Recent Development
Table 124. J&J(Crucell) Corporation Information
Table 125. J&J(Crucell) Description and Business Overview
Table 126. J&J(Crucell) Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 127. J&J(Crucell) Product
Table 128. J&J(Crucell) Recent Development
Table 129. China National Biotec Corporation Information
Table 130. China National Biotec Description and Business Overview
Table 131. China National Biotec Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 132. China National Biotec Product
Table 133. China National Biotec Recent Development
Table 134. Tiantan Corporation Information
Table 135. Tiantan Description and Business Overview
Table 136. Tiantan Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 137. Tiantan Product
Table 138. Tiantan Recent Development
Table 139. Hualan Corporation Information
Table 140. Hualan Description and Business Overview
Table 141. Hualan Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 142. Hualan Product
Table 143. Hualan Recent Development
Table 144. Kangtai Corporation Information
Table 145. Kangtai Description and Business Overview
Table 146. Kangtai Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 147. Kangtai Product
Table 148. Kangtai Recent Development
Table 149. Hissen Corporation Information
Table 150. Hissen Description and Business Overview
Table 151. Hissen Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 152. Hissen Product
Table 153. Hissen Recent Development
Table 154. Vaccines For Children (VFC) Market Trends
Table 155. Vaccines For Children (VFC) Market Drivers
Table 156. Vaccines For Children (VFC) Market Challenges
Table 157. Vaccines For Children (VFC) Market Restraints
Table 158. Vaccines For Children (VFC) Customers List
Table 159. Vaccines For Children (VFC) Distributors List
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Vaccines For Children (VFC) Product Picture
Figure 2. Global Vaccines For Children (VFC) Sales Market Share by Type in 2020 & 2027
Figure 3. Recombinant Vaccines Product Picture
Figure 4. Viral Vaccines Product Picture
Figure 5. Polysaccharide Vaccines Product Picture
Figure 6. Others Product Picture
Figure 7. Global Vaccines For Children (VFC) Sales Market Share by Application in 2020 & 2027
Figure 8. Government Institution
Figure 9. Private Sector
Figure 10. Other
Figure 11. Vaccines For Children (VFC) Report Years Considered
Figure 12. Global Vaccines For Children (VFC) Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Vaccines For Children (VFC) Market Size 2016-2027 (US$ Million)
Figure 14. Global Vaccines For Children (VFC) Sales 2016-2027 (K Doses)
Figure 15. Global Vaccines For Children (VFC) Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Vaccines For Children (VFC) Sales Market Share by Region (2016-2021)
Figure 17. Global Vaccines For Children (VFC) Sales Market Share by Region in 2020
Figure 18. Global Vaccines For Children (VFC) Revenue Market Share by Region (2016-2021)
Figure 19. Global Vaccines For Children (VFC) Revenue Market Share by Region in 2020
Figure 20. Global Vaccines For Children (VFC) Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Vaccines For Children (VFC) Revenue in 2020
Figure 22. Vaccines For Children (VFC) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Vaccines For Children (VFC) Sales Market Share by Type (2016-2021)
Figure 24. Global Vaccines For Children (VFC) Sales Market Share by Type in 2020
Figure 25. Global Vaccines For Children (VFC) Revenue Market Share by Type (2016-2021)
Figure 26. Global Vaccines For Children (VFC) Revenue Market Share by Type in 2020
Figure 27. Global Vaccines For Children (VFC) Sales Market Share by Application (2016-2021)
Figure 28. Global Vaccines For Children (VFC) Sales Market Share by Application in 2020
Figure 29. Global Vaccines For Children (VFC) Revenue Market Share by Application (2016-2021)
Figure 30. Global Vaccines For Children (VFC) Revenue Market Share by Application in 2020
Figure 31. Japan Vaccines For Children (VFC) Sales Growth Rate 2016-2027 (K Doses)
Figure 32. Japan Vaccines For Children (VFC) Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. Japan Vaccines For Children (VFC) Market Share in Global Market 2016-2027
Figure 34. Japan 5 and 10 Largest Vaccines For Children (VFC) Players Market Share by Revenue in Vaccines For Children (VFC) in 2020
Figure 35. Japan Vaccines For Children (VFC) Revenue Share by Type (2016-2021)
Figure 36. Japan Vaccines For Children (VFC) Revenue Growth Rate by Type in 2016 & 2020
Figure 37. Japan Vaccines For Children (VFC) Revenue Share by Application (2016-2021)
Figure 38. Japan Vaccines For Children (VFC) Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Vaccines For Children (VFC) Sales Growth Rate 2016-2021 (K Doses)
Figure 40. North America Vaccines For Children (VFC) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 41. North America Vaccines For Children (VFC) Sales Market Share by Country in 2020
Figure 42. North America Vaccines For Children (VFC) Revenue Market Share by Country in 2020
Figure 43. U.S. Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses)
Figure 44. U.S. Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Canada Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses)
Figure 46. Canada Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Europe Vaccines For Children (VFC) Sales Growth Rate 2016-2021 (K Doses)
Figure 48. Europe Vaccines For Children (VFC) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 49. Europe Vaccines For Children (VFC) Sales Market Share by Country in 2020
Figure 50. Europe Vaccines For Children (VFC) Revenue Market Share by Country in 2020
Figure 51. Germany Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses)
Figure 52. Germany Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. France Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses)
Figure 54. France Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. U.K. Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses)
Figure 56. U.K. Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Italy Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses)
Figure 58. Italy Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Russia Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses)
Figure 60. Russia Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Asia Pacific Vaccines For Children (VFC) Sales Growth Rate 2016-2021 (K Doses)
Figure 62. Asia Pacific Vaccines For Children (VFC) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 63. Asia Pacific Vaccines For Children (VFC) Sales Market Share by Region in 2020
Figure 64. Asia Pacific Vaccines For Children (VFC) Revenue Market Share by Region in 2020
Figure 65. China Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses)
Figure 66. China Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Japan Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses)
Figure 68. Japan Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. South Korea Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses)
Figure 70. South Korea Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. India Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses)
Figure 72. India Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Australia Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses)
Figure 74. Australia Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Taiwan Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses)
Figure 76. Taiwan Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Indonesia Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses)
Figure 78. Indonesia Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Thailand Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses)
Figure 80. Thailand Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Malaysia Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses)
Figure 82. Malaysia Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Philippines Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses)
Figure 84. Philippines Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Vietnam Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses)
Figure 86. Vietnam Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Latin America Vaccines For Children (VFC) Sales Growth Rate 2016-2021 (K Doses)
Figure 88. Latin America Vaccines For Children (VFC) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 89. Latin America Vaccines For Children (VFC) Sales Market Share by Country in 2020
Figure 90. Latin America Vaccines For Children (VFC) Revenue Market Share by Country in 2020
Figure 91. Mexico Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses)
Figure 92. Mexico Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Brazil Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses)
Figure 94. Brazil Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Argentina Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses)
Figure 96. Argentina Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Middle East and Africa Vaccines For Children (VFC) Sales Growth Rate 2016-2021 (K Doses)
Figure 98. Middle East and Africa Vaccines For Children (VFC) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 99. Middle East and Africa Vaccines For Children (VFC) Sales Market Share by Country in 2020
Figure 100. Middle East and Africa Vaccines For Children (VFC) Revenue Market Share by Country in 2020
Figure 101. Turkey Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses)
Figure 102. Turkey Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. Saudi Arabia Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses)
Figure 104. Saudi Arabia Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. UAE Vaccines For Children (VFC) Sales Growth Rate (2016-2021) (K Doses)
Figure 106. UAE Vaccines For Children (VFC) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 107. Vaccines For Children (VFC) Value Chain
Figure 108. Channels of Distribution
Figure 109. Distributors Profiles
Figure 110. Bottom-up and Top-down Approaches for This Report
Figure 111. Data Triangulation
Figure 112. Key Executives Interviewed
Keyplayers in Global and Japan Vaccines For Children (VFC) Market Insights, Forecast to 2027
GSKSanofi
Merck
Pfizer
Jintan
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen